Roche's virtual event on key data presented at the 2021 MDA Virtual Clinical & Scientific Conference

Roche has hosted a virtual event on Friday, 19^th March 2021.

Agenda:

Phase II/III SUNFISH part 2: 24-month efficacy and safety of risdiplam in patients with Type 2 or non-ambulant Type 3 spinal muscular atrophy
Paulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development
Roche Neuroscience and Rare Disease franchise update
Simona Skerjanec, Therapeutic Area Head Neuroscience and Rare Diseases, Global Product Strategy
Q&A
Karl Mahler, Head of Investor Relations and Roche Group Planning

Please register to access the webcast*

First Name

Last name

Corporate Email

Company Name

Job Role

Country

* Mandatory

Please come back 30 minutes before the webcast start date and fill in the registration form.